Searched for
ABBVIE INC.
Alembic gets USFDA nod for generic levothyroxine sodium tabletsAlembic Pharmaceuticals has secured final approval from the US health regulator for its generic levothyroxine sodium tablets. This medicati...- Glenmark Pharma will turn cash positive with AbbVie's licensing deal: S&PS&P Global Ratings projects Glenmark Pharmaceuticals will achieve a net cash positive position following its licensing agreement with AbbVi...
- Rx Name Unethical Practitioners: A medical thriller unfolds in IndiaIndia's Department of Pharmaceuticals found AbbVie Healthcare India sponsored ₹1.91 crore in international trips for 30 doctors, violating ...
- NMC starts probe against doctors over AbbVie-sponsored foreign tripsThe National Medical Commission has launched an investigation into doctors whose foreign trips, funded by AbbVie Healthcare, breached the U...
- Lupin gets USD 25 million from AbbVie for meeting key product development milestoneThe company has achieved a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor...
- Alembic gets USFDA approval to market Clarithromycin tablets in AmericaAlembic's product is therapeutically equivalent to AbbVie Inc's Biaxin Filmtab Tablets, which is antimicrobial indicated to treat mild to m...
- Alembic Pharma gets USFDA nod for cholesterol lowering drugIn a regulatory filing, Alembic Pharma said "it has received final approval from the US Food and Drug Administration (USFDA) for its abbrev...
- Dr Reddy's launches generic lipid-regulating tablets in USPharma major Dr Reddy's Laboratories on Monday said it has launched generic lipid-regulating tablets in the US market.
- Natco launches cut price versions of cancer drug ibrutinib in indiaThe patent for the drug is held by Pharmacyclics for three to four more years in India. Pharmacyclics was globally acquired by US giant Abb...
- Lupin gets USFDA nod to market its mania and epilepsy treatment drug in USThe company has received approval from the United States Food and Drug Administration (USFDA) for its Divalproex Sodium extended-release ta...
- Dr Reddy's launches generic testosterone gel in US marketThe company's testosterone gel 1.62 per cent, which is a therapeutic equivalent generic version of AndroGel 1.62 per cent of AbbVie Inc, wa...
- Lupin launches Levothyroxine Sodium tablets in USThe tablets are indicated as replacement or supplemental therapy for hypothyroidism.
- Lupin developing new products to treat cancer, other diseasesSharing details, Kamboj said the the Mumbai-based company is currently working on developing various products, including two major ones to ...
- Lupin partners with AbbVie to develop, commercialise novel oncology drugAdditionally, Lupin will be entitled to receive a double-digit royalty on the sales of the product and will retain commercial rights to the...
- Alembic Pharma's cholesterol drug gets US FDA nodThe approved product is therapeutically equivalent to the reference listed drug product Trilipix Delayed-Release capsules of Abbvie Inc.
- Glenmark gets USFDA nod to sell generic blood pressure drug TarkaThe approval for trandolapril and verapamil hydrochloride extended release tablets has been granted to Glenmark Generics Inc.
- Aurobindo gets USFDA nod to market mental illness drugAccording to IMS sales data, the product had a market size of around USD 690 million for the twelve months ended March 2014.
- Lupin launches generic Niaspan tablets in US marketThe company's US subsidiary, Lupin Pharmaceuticals Inc has launched the generic Niaspan tablets in multiple strengths of 500mg, 750 mg & 10...
- Lupin launches generic Fenofibric Acid capsules in US marketLupin said its US arm has launched generic Fenofibric Acid capsules used for reducing cholesterol and fatty acids in the blood in the Ameri...
- Dr Reddy's sued for 'infringement' of thyroid injection patentUS-based drug maker AbbVie Inc has dragged Dr Reddy's Lab to court for allegedly infringing the former's patented drug Zemplar on six count...
Load More
